Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9231667rdf:typepubmed:Citationlld:pubmed
pubmed-article:9231667lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:9231667lifeskim:mentionsumls-concept:C0072108lld:lifeskim
pubmed-article:9231667lifeskim:mentionsumls-concept:C0025286lld:lifeskim
pubmed-article:9231667lifeskim:mentionsumls-concept:C0332325lld:lifeskim
pubmed-article:9231667lifeskim:mentionsumls-concept:C0918012lld:lifeskim
pubmed-article:9231667pubmed:issue3lld:pubmed
pubmed-article:9231667pubmed:dateCreated1997-8-25lld:pubmed
pubmed-article:9231667pubmed:abstractTextMeningiomas are common intracranial tumors, often well controlled with surgical resection alone. While the efficacy of radiation therapy in improving local control and progression-free survival is well documented, prognostic data substantiate factors that are predictive of poor local control following definitive radiation therapy. PCNA is a DNA polymerase expressed at the highest levels in the S-phase, the most resistant portion of the cell cycle to ionizing radiation in vitro. We investigated the possible correlation between the levels of PCNA expression and the clinical outcome of patients treated with definitive radiation therapy.lld:pubmed
pubmed-article:9231667pubmed:languageenglld:pubmed
pubmed-article:9231667pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9231667pubmed:citationSubsetIMlld:pubmed
pubmed-article:9231667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9231667pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9231667pubmed:statusMEDLINElld:pubmed
pubmed-article:9231667pubmed:monthJunlld:pubmed
pubmed-article:9231667pubmed:issn0360-3016lld:pubmed
pubmed-article:9231667pubmed:authorpubmed-author:HsuD WDWlld:pubmed
pubmed-article:9231667pubmed:authorpubmed-author:PardoF SFSlld:pubmed
pubmed-article:9231667pubmed:authorpubmed-author:ToTTlld:pubmed
pubmed-article:9231667pubmed:authorpubmed-author:ColvettK TKTlld:pubmed
pubmed-article:9231667pubmed:authorpubmed-author:LingoodR MRMlld:pubmed
pubmed-article:9231667pubmed:issnTypePrintlld:pubmed
pubmed-article:9231667pubmed:day1lld:pubmed
pubmed-article:9231667pubmed:volume38lld:pubmed
pubmed-article:9231667pubmed:ownerNLMlld:pubmed
pubmed-article:9231667pubmed:authorsCompleteYlld:pubmed
pubmed-article:9231667pubmed:pagination463-8lld:pubmed
pubmed-article:9231667pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:meshHeadingpubmed-meshheading:9231667-...lld:pubmed
pubmed-article:9231667pubmed:year1997lld:pubmed
pubmed-article:9231667pubmed:articleTitleHigh PCNA index in meningiomas resistant to radiation therapy.lld:pubmed
pubmed-article:9231667pubmed:affiliationDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.lld:pubmed
pubmed-article:9231667pubmed:publicationTypeJournal Articlelld:pubmed